Site icon YCNews

Russia approves the third Russian-made vaccine CoviVac expert recommendations for strengthening immunity

Russia approves the third Russian-made vaccine CoviVac expert recommendations for strengthening immunity

Fact picture: Russia's first coronavirus vaccine "Sputnik V". Photo by Wang Xiujun, reporter of China News Service

February 20, Russian Prime Minister Mishustin said that Russia had approved the registration of the third Russian-made coronavirus vaccine, called CoviVac.

The vaccine was developed by the Chumakov Federal Immunization Federal Center for Immunization and Biological Products Research and Development. The first vaccine is expected to be in mid-March.

According to a report by Tass on the 20th, Mishustin announced at a conference on the coronavirus vaccine that the third domestic coronavirus vaccine in Russia, CoviVac, developed by the Chumakov Federal Center for Research and Development of Immunization and Biological Products, has been registered, and the first 120,000 doses of vaccine will be held in mid-March.

Put it on the market. Mishustin stressed that Russia is the only country that currently has three domestic vaccines.

“CoviVac is better suited to strengthen immunity than two other domestic vaccines,” said Albert Rizvanov, director of the Clinical Center for Precision and Regenerative Medicine Research at Kazan Federal University.

“If someone has already had COVID-19 and needs to build up their immunity after a certain amount of time, I think the vaccine is a better option.” “It will help restore the ‘immune memory’ of an organism, boosting it when immunity begins to decline in 10 to 12 months,” Rizvanov said.

According to Xinhua News Agency, Russia currently has three registered domestic vaccines, of which CoviVac is an inactivated vaccine, the first “Sputnik V” registered in August last year is adenovirus vector vaccine, and EpiVacCorona registered in October last year is a synthetic peptide vaccine.

Russia has produced more than 10 million doses of “Sputnik V” vaccine and about 80,000 doses of EpiVacCorona vaccine, and industrial production of CoviVac vaccine will begin in the near future.

Exit mobile version